Candid Therapeutics raised $370M in a Series A funding round to develop antibody drugs for inflammatory diseases.
Amount Raised
$370 Million
Round Type
Series A
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Candid Therapeutics, a new biotech company, secured over $370 million in funding to develop treatments for autoimmune diseases. The funding will allow them to operate for several years and explore opportunities for an initial public offering.
Quick answer
Candid Therapeutics raised $370 Million in a Series A round, dated September 9, 2024. Candid Therapeutics is based in San Diego, California, United States.
- How much did Candid Therapeutics raise?
- Candid Therapeutics raised $370 Million in a Series A round on September 9, 2024.
- What does Candid Therapeutics do?
- Candid Therapeutics is a biotechnology startup focused on developing antibody drugs specifically for inflammatory diseases.
- Where is Candid Therapeutics based and how big is it?
- Candid Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Candid Therapeutics?
- Fundz holds 1 contact at Candid Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Candid Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $62M on October 24, 2024.
- Ensho Therapeutics raised $5M on October 24, 2024.
- AvenCell Therapeutics raised $112M (Series B) on October 22, 2024.
- Passkey Therapeutics raised $20M (Seed) on October 22, 2024.
- TenNor Therapeutics raised $41M (Series E) on October 16, 2024.
- invIOs raised $8.9M (Series A) on October 15, 2024.
Who to call at Candid Therapeutics, and when
A new round usually means Candid Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Candid Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Candid Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Candid Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Candid Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCandid Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.